HLA Alleles and COVID-19 Severity
Author Information
Author(s): Tymoniuk Bogusław, Borowiec Maciej, Makowska Joanna, Holwek Emilia, Sarnik Joanna, Styrzyński Filip, Dróżdż Izabela, Lewiński Andrzej, Stasiak Magdalena
Primary Institution: Medical University of Lodz
Hypothesis
The study aims to compare the HLA profiles of patients with symptomatic SARS-CoV-2 infection and a healthy control group, as well as to compare HLA allele frequencies in patients with severe and non-severe courses of COVID-19.
Conclusion
The study identifies specific HLA alleles associated with symptomatic SARS-CoV-2 infection and the severe course of COVID-19, suggesting a genetic predisposition to the disease.
Supporting Evidence
- HLA-A*30:01, B*44:02, B*52:01, C*05:01, C*17:01, and DRB1*11:02 are associated with symptomatic COVID-19.
- HLA-C*07:04 and DQB1*03:03 seem to play a protective role against symptomatic COVID-19.
- HLA-B*08:01, C*04:01, DRB1*03:01, and DQB1*03:01 are associated with severe COVID-19.
- HLA-DRB1*08:01 appears to be protective against severe COVID-19.
Takeaway
Some people have genes that make them more likely to get really sick from COVID-19, while others have genes that help protect them.
Methodology
HLA classes were genotyped using next-generation sequencing in 2322 individuals, including 2217 healthy donors and 105 patients with symptomatic COVID-19.
Potential Biases
The study may have bias due to the uneven distribution of severe COVID-19 cases among participants.
Limitations
The study's sample size for symptomatic COVID-19 patients was small, and it lacked data on pre-existing conditions that may influence disease outcomes.
Participant Demographics
The study included 2322 participants, with 2217 healthy Caucasian hematopoietic stem cell potential donors and 105 symptomatic COVID-19 patients.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website